Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06541002 · ClinicalTrials.gov registry record · NA
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
A NA study of Sexual Dysfunction and Stem Cell Transplant Complications, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT06541002: Recruiting NA study of Sexual Dysfunction and Stem Cell Transplant Complications, sponsored by Massachusetts General Hospital.
NCT06541002 is a NA study of Sexual Dysfunction and Stem Cell Transplant Complications that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 300 participants, below the 953-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06541002, a NA study of Sexual Dysfunction and Stem Cell Transplant Complications, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.
Primary Outcome
To compare patient global satisfaction with sex scores at week 8 after enrollment between those receiving SHIFT versus enhanced usual care as measured by the PROMIS global satisfaction with sex domain from the PROMIS Scale v2.0 Satisfaction with Sex Life. Higher scores indicate higher satisfaction with sex life, and lower scores indicate less satisfaction with sex life.
Conditions Studied
Interventions
- BEHAVIORAL SHIFT Intervention Group
- BEHAVIORAL Enhanced Usual Care Group
Study Locations (3)
Florida
- University of Miami - Coral Gables
Massachusetts
- Massachusetts General Hospital (MGH) - Boston
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
What NCT06541002 shows while recruiting
NCT06541002 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 953-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (69% lower).
The record links to 3 conditions, with Sexual Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which SHIFT Intervention Group is the first listed.
NCT06541002 reports a single indexed study location in Florida, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06541002 about?
NCT06541002 is a clinical study titled "A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors". This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.
What is the current status of trial NCT06541002?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-27. Estimated completion is 2030-04-30.
What conditions does trial NCT06541002 study?
This clinical trial studies the following conditions: Sexual Dysfunction, Stem Cell Transplant Complications, Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT06541002?
The interventions under investigation include: SHIFT Intervention Group (BEHAVIORAL), Enhanced Usual Care Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT06541002?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06541002 being conducted?
This trial has 3 study locations across Florida, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06541002's enrollment target sits among peer trials
300 4th of 20 higher than 17 of 20 other Sexual Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexual Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
-
Prostate Stimulation for Sexual Dysfunction
RECRUITING · NA
-
AYA OMGYES Sexual Health Study
RECRUITING · NA
-
Improving Women's Function After Pelvic Radiation
ACTIVE NOT RECRUITING · NA
-
Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI